Table 1.
Animal model* | Panels: human (H); conserved (C) | ||||
Gene symbol | Protein name | ApcMin/+ vs. +/+ | ApcPirc/+ vs. +/+ | This report† | |
APCS | Serum amyloid P-component | 1 | ND | 0 | |
CD44 | CD44 antigen | 3 | 0 | 0 | |
CDH2 | Cadherin 2, type 1, N-Cadherin (neuronal) | 3 | ND | 0 | |
CFI | Complement factor I | 2 | 0 | 0 | |
CRP | C-reactive protein, pentraxin-related | 2 | ND | E | H |
DPP4 | Dipeptidyl-peptidase 4 | 3 | ND | 0 | |
EGFR | Epidermal growth factor receptor | 1 | D | 0 | |
F5 | Coagulation factor V | 2 | E | E | H, C |
FETUB | Fetuin B | 1 | ND | 0 | |
HPX | Hemopexin | 2 | E | 0 | |
ITIH3 | Inter-α trypsin inhibitor, heavy chain H3 | 1 | 0 | 0 | |
ITIH4 | Inter-α trypsin inhibitor, heavy chain 4 | 1 | E | E | H, C |
LRG1 | Leucine-rich α-2 glycoprotein | 1 | E | E | H, C |
PI16 | Peptidase inhibitor 16 | 3 | ND | D | |
QSOX1 | Quiescin Q6 sulfhydryl oxidase 1 | 2 | ND | E | |
SOD3 | Superoxide dismutase 3, extracellular | 3 | ND | 0 | |
THBS4 | Thrombospondin 4 | 3 | ND | 0 | |
VITDBP | Vitamin D-binding protein | 1 | ND | 0 | |
VTN | Vitronectin | 1 | E | E | H, C |
ApcMin/+ vs. +/+ data from Ivancic et al. (6): 1, high-replicate, high–statistical-confidence proteins were identified as being statistically differentially expressed in at least three out of four samples at the 52- and/or 66-d time points. Statistical significance was defined as having a U value less than 0.05 and a corresponding q value less than 0.05. 2, The category with high replicates but reduced statistical confidence included proteins that had statistically relevant differential expression in only one reciprocally labeled sample, or single peptide identifications where no statistical calculations could be made. 3, The proteins with low-replicate results that had little or no statistical substantiation either displayed no reciprocal sample validation, or the protein had only a single unique peptide hit changing at a log2 ratio of 1.0 or greater. ApcPirc/+ vs. +/+ data from Ivancic et al. (7): 0, no significant difference observed; D, diminished in sera from the F1 ApcPirc/+ rat vs. F1 wild-type rats; E, enhanced in sera from the F1 ApcPirc/+ rat vs. F1 wild-type rats; ND, not detected.
This report: 0, no significant difference observed; D, diminished in polyps; E, enhanced in growing adenomas.